Forum 2-1: Next Generation Peptides, Peptidomimetics, and bRo5 and Cyclopeptide

Day 1: Afternoon, May 11, 2022

Chair

Call for Chair

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:05

Speech Opportunity Available

14:05-14:30

Speech Opportunity Available

14:30-14:55

Speech Opportunity Available

14:55-15:20

Speech Opportunity Available

15:20-15:30

Coffee Break

15:30-15:55

Speech Opportunity Available

15:55-16:20

Speech Opportunity Available

16:20-16:45

Speech Opportunity Available

16:45-17:10

Speech Opportunity Available

Forum 2-2: Fusion Protein Drugs

Day 1: Afternoon, May 11, 2022

Chair

Call for Chair

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:05

Speech Opportunity Available

14:05-14:30

Speech Opportunity Available

14:30-14:55

Speech Opportunity Available

14:55-15:20

Speech Opportunity Available

15:20-15:30

Coffee Break

15:30-15:55

Speech Opportunity Available

15:55-16:20

Speech Opportunity Available

16:20-16:45

Speech Opportunity Available

16:45-17:10

Speech Opportunity Available

Forum 2-3: ASO, siRNA, micro-RNA, and other Modified Oligonucleotides

Day 1: Afternoon, May 11, 2022

Chair

Call for Chair

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:05

Speech Opportunity Available

14:05-14:30

Speech Opportunity Available

14:30-14:55

Speech Opportunity Available

14:55-15:20

Speech Opportunity Available

15:20-15:30

Coffee Break

15:30-15:55

Speech Opportunity Available

15:55-16:20

Speech Opportunity Available

16:20-16:45

Speech Opportunity Available

16:45-17:10

Speech Opportunity Available

Forum 2-4: Emerging Cell Repair, Regeneration and Therapies

Day 2: Morning, May 12, 2022

Chair

Call for Chair

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Speech Opportunity Available

09:00-09:25

Speech Opportunity Available

09:25-09:50

Speech Opportunity Available

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

10:30-10:50

Speech Opportunity Available

10:50-11:15

Speech Opportunity Available

11:15-11:40

Speech Opportunity Available

11:40-12:05

Speech Opportunity Available

Forum 2-5: New Gene Therapy

Day 2: Morning, May 12, 2022

Chair

Dr. Nagy Habib, Head of R&D, MiNA Therapeutics Ltd., USA

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Speech Opportunity Available

09:00-09:25

Title: First in Class, First in Humans RNA to CEBP Alpha in Patients with Advanced Malignancies

Dr. Nagy Habib, Head of R&D, MiNA Therapeutics Ltd., USA

09:25-09:50

Speech Opportunity Available

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

10:30-10:50

Speech Opportunity Available

10:50-11:15

Speech Opportunity Available

11:15-11:40

Speech Opportunity Available

11:40-12:05

Speech Opportunity Available

Forum 2-6: Stabilized a-helices and b-sheets

Day 2: Morning, May 12, 2022

Chair

Call for Chair

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Speech Opportunity Available

09:00-09:25

Speech Opportunity Available

09:25-09:50

Speech Opportunity Available

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

10:30-10:50

Speech Opportunity Available

10:50-11:15

Speech Opportunity Available

11:15-11:40

Speech Opportunity Available

11:40-12:05

Speech Opportunity Available

Forum 2-7: Foldmers and Aptamers

Day 2: Afternoon, May 12, 2022

Chair

Call for Chair

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:05

Speech Opportunity Available

14:05-14:30

Speech Opportunity Available

14:30-14:55

Speech Opportunity Available

14:55-15:20

Speech Opportunity Available

15:20-15:30

Coffee Break

15:30-15:55

Speech Opportunity Available

15:55-16:20

Speech Opportunity Available

16:20-16:45

Speech Opportunity Available

16:45-17:10

Speech Opportunity Available

Forum 2-8: Designed-multiple ligands (DML) for polypharmacology

Day 2: Afternoon, May 12, 2022

Chair

Call for Chair

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:05

Speech Opportunity Available

14:05-14:30

Speech Opportunity Available

14:30-14:55

Speech Opportunity Available

14:55-15:20

Speech Opportunity Available

15:20-15:30

Coffee Break

15:30-15:55

Speech Opportunity Available

15:55-16:20

Speech Opportunity Available

16:20-16:45

Speech Opportunity Available

16:45-17:10

Speech Opportunity Available

Forum 2-9: PROTACs Degraders, Mixed Drug Modalities

Day 3: Morning, May 13, 2022

Chair

Call for Chair

Time

Speeches and Speakers

08:30-08:35

Chair’s Introduction

08:35-09:00

Speech Opportunity Available

09:00-09:25

Speech Opportunity Available

09:25-09:50

Speech Opportunity Available

09:50-10:15

Speech Opportunity Available

10:15-10:30

Coffee Break

10:30-10:50

Speech Opportunity Available

10:50-11:15

Speech Opportunity Available

11:15-11:40

Speech Opportunity Available

11:40-12:05

Speech Opportunity Available

Forum 2-10: Molecular Probes, Dendrimer Conjugates and Mixed New Modalities

Day 3: Afternoon, May 13, 2022

Chair

Call for Chair

Time

Speeches and Speakers

13:30-13:35

Chair’s Introduction

13:35-14:05

Speech Opportunity Available

14:05-14:30

Speech Opportunity Available

14:30-14:55

Speech Opportunity Available

14:55-15:20

Speech Opportunity Available

15:20-15:30

Coffee Break

15:30-15:55

Speech Opportunity Available

15:55-16:20

Speech Opportunity Available

16:20-16:45

Speech Opportunity Available

16:45-17:10

Speech Opportunity Available